Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
HUMIRA
Sort By
Newest First
Sign in
1 / 1
1 / 1
Positive Results
Lilly Presents Positive Results for Taltz® vs. Humira®in Patients with Active Psoriatic Arthritis
Eli Lilly and Company
PR-M06-19-NI-023
Jun 18, 2019
Legal
AbbVie Resolves HUMIRA® (adalimumab) U.S. Patent Litigation with Boehringer Ingelheim
AbbVie
PR-M05-19-NI-056
May 20, 2019
Drug Development
Entyvio Outperforms Humira As an Ulcerative Colitis Therapy
Nice Insight
PAO-M03-19-NI-020
Mar 12, 2019
Licensing Agreement
Pfizer to License AbbVie’s Humira IP
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M12-18-NI-006
Dec 05, 2018
Patent
Humira Patent Disputes between Novartis and Abbvie Settled
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M10-18-NI-021
Oct 22, 2018
Biosimilars
GlobalData Predicts Strong Sales for Humira Biosimilars in Europe
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M05-18-NI-006
May 10, 2018
Biosimilar
Another Biosimilar Gets FDA Nod
Guy Tiene
Nice Insight
PAO-M09-17-NI-011
Sep 08, 2017
